Coronavirus Disease 2019 (COVID-19) Mitigation Efforts and Testing During an In-Person Training Event-Uganda, 12-29 October 2020.

COVID-19 COVID-19 Testing COVID-19 Vaccines Humans SARS-CoV-2 Uganda
COVID-19 SARS-CoV-2 mitigation testing trainings

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
15 07 2021
Historique:
pubmed: 30 4 2021
medline: 21 7 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

Large public-health training events may result in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Universal SARS-CoV-2 testing during trainings for the Uganda Population-based HIV Impact Assessment identified 28 of 475 (5.9%) individuals with coronavirus disease 2019 (COVID-19) among attendees; most (89.3%) were asymptomatic. Until COVID-19 vaccine is readily available for staff and participants, effective COVID-19 mitigation measures, along with SARS-CoV-2 testing, are recommended for in-person trainings, particularly when trainees will have subsequent contact with survey participants.

Identifiants

DOI: 10.1093/cid/ciab331 PMID: 33912911 PMC: PMC8135603
pubmed: 33912911
pii: 6257593
doi: 10.1093/cid/ciab331
pmc: PMC8135603
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S42-S44

Subventions

Organisme : PEPFAR
ID : NU2GGH002173
Pays : United States

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2021.

Auteurs

Rebecca L Laws (RL)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sam Biraro (S)

ICAP at Columbia University, Kampala, Uganda.

Wilford Kirungi (W)

Uganda Ministry of Health, Kampala, Uganda.

Brittany Gianetti (B)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.

Dorothy Aibo (D)

ICAP at Columbia University, Kampala, Uganda.

Anna C Awor (AC)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.

Christine West (C)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Karampreet K Sachathep (KK)

ICAP at Columbia University, New York, New York, USA.

Herbert Kiyingi (H)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.

Jennifer Ward (J)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.

Christina Mwangi (C)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.

Peter Nkurunziza (P)

ICAP at Columbia University, Kampala, Uganda.

David Okimait (D)

ICAP at Columbia University, Kampala, Uganda.

Dustin Currie (D)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Aderonke Ajiboye (A)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Carole S Moore (CS)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Hetal Patel (H)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sam Sendagala (S)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.

Mary Naluguza (M)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.

Veronicah Mugisha (V)

ICAP at Columbia University, New York, New York, USA.

Andrea Low (A)

ICAP at Columbia University, New York, New York, USA.

Stephen Delgado (S)

ICAP at Columbia University, New York, New York, USA.

David Hoos (D)

ICAP at Columbia University, New York, New York, USA.

Kristin Brown (K)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jennifer S Galbraith (JS)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Wolfgang Hladik (W)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Lisa Nelson (L)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.

Wafaa El-Sadr (W)

ICAP at Columbia University, New York, New York, USA.

Joshua Musinguzi (J)

Uganda Ministry of Health, Kampala, Uganda.

Andrew C Voetsch (AC)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Coronavirus Disease 2019 (COVID-19) Mitigation...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Dépistage de la COVID-19 › Coronavirus Disease 2019 (COVID-19) Mitigation...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre la COVID-19 › Coronavirus Disease 2019 (COVID-19) Mitigation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Coronavirus Disease 2019 (COVID-19) Mitigation...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Coronavirus Disease 2019 (COVID-19) Mitigation...
questionsmedicales.fr › Régions géographiques › Afrique › Afrique subsaharienne › Afrique de l'Est › Ouganda › Coronavirus Disease 2019 (COVID-19) Mitigation...